Low IGF-1 levels due to GH resistance (46), low sex hormone levels due to functional hypogonadotropic hypogonadism (33), elevated cortisol (47) and low leptin levels (22) all contribute to low bone mass observed in patients with AN. This evidence concerns the gene IGF1 and hypogonadotropic hypogonadism.